中文 | English
Return
Total: 2 , 1/1
Show Home Prev Next End page: GO
Author:(Quchang OUYANG)

1.Preliminary study on quantitative proteomic analysis of differentially expressed proteins in HER-2 posi-tive and negative breast cancer

Jing LI ; Sanqian HUANG ; Quchang OUYANG ; Jingmin ZHONG ; Nina GAO ; Liping LIU ; Zhihong LIU ; Liang ZENG

Journal of International Oncology 2016;43(10):721-727

2.Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial.

Binghe XU ; Qingyuan ZHANG ; Xichun HU ; Qing LI ; Tao SUN ; Wei LI ; Quchang OUYANG ; Jingfen WANG ; Zhongsheng TONG ; Min YAN ; Huiping LI ; Xiaohua ZENG ; Changping SHAN ; Xian WANG ; Xi YAN ; Jian ZHANG ; Yue ZHANG ; Jiani WANG ; Liang ZHANG ; Ying LIN ; Jifeng FENG ; Qianjun CHEN ; Jian HUANG ; Lu ZHANG ; Lisong YANG ; Ying TIAN ; Hongyan SHANG

Acta Pharmaceutica Sinica B 2023;13(5):2250-2258

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 2 , 1/1 Show Home Prev Next End page: GO